On this page

Digibind

Digoxin Immune Fab (Ovine)

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Digibind
Proper name
Digoxin Immune Fab (Ovine)
Licence type
351(a)
BLA number
103141
Applicant
Wellcome Foundation Limited Wellcome Research Laboratories
Center
CBER
Presentations
1
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
38MG For Injection Intravenous Single-Dose Vial Disc April 22, 1986

Exclusivity

Source: Purple Book
Kind Expires
Orphan exclusivityApril 22, 1993

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity